Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Allena Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 25 | 2 | −23 |
| Shares | 8.95M | 252.6K | −8.70M (−97.2%) |
| Value | $1.71M | $4.00K | −$1.70M (−99.8%) |
New holders (0)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
None.
Sold out (23)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| TRV GP II, LLC | 2,790,964 | $533.0K |
| Vanguard Group Inc | 2,682,145 | $512.0K |
| Geode Capital Management, LLC | 386,352 | $73.0K |
| Two Sigma Securities, LLC | 357,044 | $68.0K |
| BlackRock Inc. | 228,215 | $44.0K |
| State Street Corp | 205,058 | $39.0K |
| Citigroup Inc | 174,988 | $33.0K |
| Millennium Management LLC | 173,798 | $33.0K |
| Kestra Advisory Services, LLC | 164,662 | $31.0K |
| FMR LLC | 106,183 | $20.0K |
| Northern Trust Corp | 89,363 | $17.0K |
| UBS Group AG | 83,827 | $16.0K |
| Susquehanna International Group, LLP | 65,789 | $13.0K |
| Level Four Advisory Services, LLC | 40,000 | $8.00K |
| LPL Financial LLC | 30,550 | $6.00K |
| Advisor Group Holdings, Inc. | 33,000 | $6.00K |
| Golden Green, Inc. | 25,000 | $5.00K |
| Renaissance Technologies LLC | 17,200 | $3.00K |
| Prospera Financial Services Inc | 10,800 | $2.00K |
| Spire Wealth Management | 10,053 | $2.00K |
| Bank of America Corp | 5,800 | $1.00K |
| Wells Fargo & Company | 3,053 | $0 |
| Morgan Stanley | 6 | $0 |